share_log

BUZZ-HK-listed WuXi Biologics leads slide in pharma stocks on Merck COVID-19 pill success

BUZZ-HK-listed WuXi Biologics leads slide in pharma stocks on Merck COVID-19 pill success

在香港上市的药明生物领跌制药股,默克新冠肺炎药丸取得成功
reuters ·  2021/10/04 02:38

** Shares of WuXi Biologics 2269.HK lead slide in antibody and vaccines producers, falling 8.1% in their biggest daily percentage decline since July 26, after positive clinical trial results for Merck & Co's MRK.N experimental antiviral COVID-19 pill

*药明生物的股价在抗体和疫苗生产商中领跌,下跌8.1%,这是自7月26日以来的最大单日百分比跌幅,此前默克公司的MRK.N实验性抗病毒新冠肺炎片的临床试验结果呈阳性

** Stock on track to snap four straight sessions of gains - biggest pct decliner on Hang Seng Index .HSI

*股票有望结束连续四个交易日的上涨-恒生指数.HSI跌幅最大

** Sino Biopharmaceutical 1177.HK drops 6.7% to HK$6.03, lowest since August 2019; the third biggest decliner on the benchmark index

*中国生物制药1177.HK下跌6.7%,至6.03港元,为2019年8月以来的最低水平;为基准指数第三大跌幅

** Data in a clinical trial showed Merck's antiviral pill for coronavirus could halve the chances of dying or being hospitalized for those most at risk of contracting severe COVID-19, boosting its stock on Friday while denting shares of vaccine and coronavirus therapies makers

*一项临床试验的数据显示,默克公司的冠状病毒抗病毒药片可以将那些最有可能感染严重新冠肺炎的人的死亡或住院几率减半,这在周五提振了默克的股价,同时削弱了疫苗和冠状病毒疗法制造商的股价

** Merck and partner Ridgeback Biotherapeutics said they plan to seek U.S. emergency use authorization for the pill as soon as possible and to make regulatory applications worldwide

*默克公司及其合作伙伴Ridgeback BioTreateutics表示,他们计划尽快寻求美国对该药片的紧急使用授权,并在全球范围内进行监管申请

** In Hong Kong, Kintor Pharmaceutical 9939.HK plunges

*在香港,Kintor制药9939.HK暴跌

26.3%, the biggest daily percentage decline since listing in May

26.3%,为5月上市以来最大单日百分比跌幅

2020

2020

** CanSino Biologics 6185.HK drops 29.5%, the worst day since listing in March 2019

*Cansino Biologics 6185.HK下跌29.5%,为2019年3月上市以来表现最差的一天

** Shanghai Fosun Pharmaceutical 2196.HK slumps 21%, the worst session since listing in October 2012

*复星医药2196.HK暴跌21%,为2012年10月上市以来表现最差的一个交易日

** Healthcare index .HSCIH drops 4.8%, the Hang Seng Composite Index .HSCI falls 1.8%, and Hang Seng index .HSI falls 2.2%

*医疗保健指数.HSCIH下跌4.8%,恒生综合指数.HSCI下跌1.8%,恒生指数.HSI下跌2.2%

(Reporting by Donny Kwok)

(Donny Kuo报道)

((donny.kwok@thomsonreuters.com))

(donny.kwok@thomsonreurs.com)

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发